Application 200540
- Type
- ANDA
- Sponsor
- EXELA HOLDINGS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DICLOFENAC SODIUM AND MISOPROSTOL | DICLOFENAC SODIUM; MISOPROSTOL | TABLET, DELAYED RELEASE;ORAL | 50MG;0.2MG | No | No |
| 002 | DICLOFENAC SODIUM AND MISOPROSTOL | DICLOFENAC SODIUM; MISOPROSTOL | TABLET, DELAYED RELEASE;ORAL | 75MG;0.2MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200540-001 | DICLOFENAC SODIUM AND MISOPROSTOL | DICLOFENAC SODIUM; MISOPROSTOL | 50MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | ||
| A200540-002 | DICLOFENAC SODIUM AND MISOPROSTOL | DICLOFENAC SODIUM; MISOPROSTOL | 75MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A200540-001 | DICLOFENAC SODIUM AND MISOPROSTOL | 50MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A200540-002 | DICLOFENAC SODIUM AND MISOPROSTOL | 75MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A200540-001 | DICLOFENAC SODIUM AND MISOPROSTOL | 50MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A200540-002 | DICLOFENAC SODIUM AND MISOPROSTOL | 75MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A200540-001 | DICLOFENAC SODIUM AND MISOPROSTOL | 50MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A200540-002 | DICLOFENAC SODIUM AND MISOPROSTOL | 75MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A200540-001 | DICLOFENAC SODIUM AND MISOPROSTOL | 50MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A200540-002 | DICLOFENAC SODIUM AND MISOPROSTOL | 75MG;0.2MG | TABLET, DELAYED RELEASE / ORAL | 2014-03-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-09-15 20:21 UTC | 2019-09 | A200540-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200540-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A200540-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200540-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Mylan Pharmaceuticals Inc. | a7701e8c-4e16-4165-8b83-de2c08d5ded3 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | Diclofenac sodium and Misoprostol |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Actavis Pharma, Inc. | df8b8660-0c24-4848-8bea-c1b935090c66 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | Diclofenac Sodium and Misoprostol |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | AvKARE | 3643ab1b-9f8f-b2f4-e02d-950d0a02e587 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | Diclofenac Sodium and Misoprostol |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | BluePoint Laboratories | 9a22cb4b-e49a-4bd7-b235-47405c302658 | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | Diclofenac Sodium and Misoprostol |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Amneal Pharmaceuticals LLC | afd30051-8f59-474b-9972-962a5a871dfb | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | Diclofenac Sodium and Misoprostol |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Bryant Ranch Prepack | d6671b66-00ad-4949-b51a-36e1130b1cb5 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | Diclofenac Sodium and Misoprostol |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10544-955 | Diclofenac Sodium and Misoprostol | Diclofenac Sodium and Misoprostol | Blenheim Pharmacal, Inc. | ANDA | Current |
| 42367-110 | Diclofenac Sodium and Misoprostol | Diclofenac Sodium and Misoprostol | Eagle Pharmaceuticals, Inc. | ANDA | Current |
| 42367-111 | Diclofenac Sodium and Misoprostol | Diclofenac Sodium and Misoprostol | Eagle Pharmaceuticals, Inc. | ANDA | Current |
| 69339-123 | Diclofenac Sodium and Misoprostol | Diclofenac Sodium and Misoprostol | Dash Pharmaceuticals LLC | ANDA | Current |
| 69339-124 | Diclofenac Sodium and Misoprostol | Diclofenac Sodium and Misoprostol | Dash Pharmaceuticals LLC | ANDA | Current |